AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21772125 — intervention group
Group type: EXPERIMENTAL
Intervention: High circulating syndecan‐1
Number of subjects: 75
Study 21772125 — intervention group
Group type: EXPERIMENTAL
Intervention: Syndecan‐1
Number of subjects: 75
Study 18931896 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril 8 mg once daily
Number of subjects: 12218
Study 18931896 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12218
Study 16689402 — intervention group
Group type: EXPERIMENTAL
Intervention: Family management styles (FMSs)
Number of subjects: 0
Study 15558087 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual toothbrush (Group M)
Number of subjects: 59
Study 15558087 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrically powered toothbrush (Group E)
Number of subjects: 59
Study 15558087 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual toothbrush and chlorhexidine gluconate (CHX) spray (Group MC)
Number of subjects: 59
Study 15558087 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrically powered toothbrush and CHX spray (Group EC)
Number of subjects: 59
Study 15558087 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine gluconate (CHX) spray (Group C)
Number of subjects: 59
Study 15568420 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous running non-absorbable or slowly absorbed suture (polydioxanone)
Number of subjects: 0
Study 15568420 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral paramedian incision
Number of subjects: 0
Study 15568420 — intervention group
Group type: COMPARATOR
Intervention: Transverse abdominal incisions
Number of subjects: 0
Study 15568420 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater number of stitches with a suture length to wound ratio of at least 4:1
Number of subjects: 0
Study 15568420 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal tension on closure
Number of subjects: 0
Study 10529323 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadroparin 6 group (86 anti-Xa IU/kg for 6 days)
Number of subjects: 3468
Study 10529323 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadroparin 14 group (86 anti-Xa IU/kg for 14 days)
Number of subjects: 3468
Study 10529323 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadroparin 14 group
Number of subjects: 3468
Study 10529323 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin group
Number of subjects: 3468
Study 7768249 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin (IV loading dose 125 micrograms, followed by IV infusion of 125 micrograms.h‐1)
Number of subjects: 9
Study 7768249 — intervention group
Group type: EXPERIMENTAL
Intervention: Loxiglumide (10 mg.kg‐1.h‐1)
Number of subjects: 9
Study 7768249 — intervention group
Group type: COMPARATOR
Intervention: Control saline
Number of subjects: 9
Study 2180577 — intervention group
Group type: EXPERIMENTAL
Intervention: Urografin
Number of subjects: 287
Study 2180577 — intervention group
Group type: EXPERIMENTAL
Intervention: iopamidol
Number of subjects: 287
Study 2180577 — intervention group
Group type: EXPERIMENTAL
Intervention: iohexol
Number of subjects: 287
Study 7419830 — intervention group
Group type: EXPERIMENTAL
Intervention: Lodoxamide tromethamine (0.01 mg)
Number of subjects: 10
Study 7419830 — intervention group
Group type: EXPERIMENTAL
Intervention: Lodoxamide tromethamine (0.1 mg)
Number of subjects: 10
Study 7419830 — intervention group
Group type: EXPERIMENTAL
Intervention: Lodoxamide tromethamine (1.0 mg)
Number of subjects: 10
Study 7419830 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 29252140 — intervention group
Group type: EXPERIMENTAL
Intervention: MOBIDERM Autofit night arm sleeve (night-user group)
Number of subjects: 40
Study 29252140 — intervention group
Group type: COMPARATOR
Intervention: No night compression (no night-user group)
Number of subjects: 40
Study 25763776 — intervention group
Group type: COMPARATOR
Intervention: Inferior vena cava clamping
Number of subjects: 50
Study 25763776 — intervention group
Group type: EXPERIMENTAL
Intervention: Reverse Trendelenburg position
Number of subjects: 50
Study 25763776 — intervention group
Group type: COMPARATOR
Intervention: Trendelenburg position
Number of subjects: 50
Study 25763776 — intervention group
Group type: COMPARATOR
Intervention: Hypoventilation anesthesia
Number of subjects: 50
Study 23276415 — intervention group
Group type: EXPERIMENTAL
Intervention: Calaxo screw
Number of subjects: 60
Study 23276415 — intervention group
Group type: COMPARATOR
Intervention: Milagro screw
Number of subjects: 60
Study 20630631 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular condylar movement exercises
Number of subjects: 148
Study 20630631 — intervention group
Group type: COMPARATOR
Intervention: No exercise (control)
Number of subjects: 148
Study 18806833 — intervention group
Group type: EXPERIMENTAL
Intervention: G‐CSF+EPO
Number of subjects: 28
Study 18806833 — intervention group
Group type: COMPARATOR
Intervention: G‐CSF
Number of subjects: 28
Study 17141945 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent androgen suppression (IAS)
Number of subjects: 29
Study 17141945 — intervention group
Group type: EXPERIMENTAL
Intervention: Subsequent cycles of androgen withdrawal
Number of subjects: 29
Study 17141945 — intervention group
Group type: EXPERIMENTAL
Intervention: Androgen withdrawal
Number of subjects: 29
Study 15090958 — intervention group
Group type: EXPERIMENTAL
Intervention: Albumin (25 g of a 25% solution every 8 hrs for a total of nine doses)
Number of subjects: 20
Study 15090958 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline administered in identical fashion and volume)
Number of subjects: 20
Study 15090958 — intervention group
Group type: EXPERIMENTAL
Intervention: Albumin treatment group
Number of subjects: 20
Study 15090958 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 20
Study 11231447 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated alteplase
Number of subjects: 1784
Study 11231447 — intervention group
Group type: COMPARATOR
Intervention: Streptokinase monotherapies
Number of subjects: 1784
Study 11231447 — intervention group
Group type: COMPARATOR
Intervention: No prior CABG
Number of subjects: 1784
Study 11231447 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with prior CABG
Number of subjects: 1784
Study 9473973 — intervention group
Group type: EXPERIMENTAL
Intervention: Keeping-track of the same changing attribute
Number of subjects: 0
Study 9473973 — intervention group
Group type: COMPARATOR
Intervention: Keeping-track of different changing attributes
Number of subjects: 0
Study 9473973 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing number of information events intervening between presentation and recall
Number of subjects: 0
Study 7531868 — intervention group
Group type: EXPERIMENTAL
Intervention: Therevac SB
Number of subjects: 10
Study 7531868 — intervention group
Group type: COMPARATOR
Intervention: Bisacodyl suppositories
Number of subjects: 10
Study 29373170 — intervention group
Group type: EXPERIMENTAL
Intervention: Part video clips
Number of subjects: 7
Study 29373170 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-second video clips
Number of subjects: 7
Study 29373170 — intervention group
Group type: COMPARATOR
Intervention: Full video clips
Number of subjects: 7
Study 29373170 — intervention group
Group type: EXPERIMENTAL
Intervention: Shorter video clips (part and 30-second)
Number of subjects: 7
Study 27490086 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes-specific preparation protocol (DSP)
Number of subjects: 150
Study 27490086 — intervention group
Group type: COMPARATOR
Intervention: Conventional bowel preparation protocol (CBP)
Number of subjects: 150
Study 24796059 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy (sword-like needle + chiropractic spinal manipulation)
Number of subjects: 138
Study 24796059 — intervention group
Group type: COMPARATOR
Intervention: Chiropractic spinal manipulation
Number of subjects: 138
Study 22717198 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive nutrition and lifestyle educational intervention (n=72)
Number of subjects: 144
Study 22717198 — intervention group
Group type: COMPARATOR
Intervention: Noncomprehensive approach (comparison group n=72)
Number of subjects: 144
Study 20526718 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous amoxicillin plus clavulanic acid 1 g every 8 h followed by oral antibiotic after improvement and discharge the next day.
Number of subjects: 50
Study 20526718 — intervention group
Group type: COMPARATOR
Intervention: Intravenous amoxicillin plus clavulanic acid for 7 days followed by oral antibiotic at discharge.
Number of subjects: 50
Study 19127910 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture plus medication (routine western medicine)
Number of subjects: 60
Study 19127910 — intervention group
Group type: COMPARATOR
Intervention: Medication (routine western medicine)
Number of subjects: 60
Study 16721316 — intervention group
Group type: EXPERIMENTAL
Intervention: Short course of family-based therapy (FBT)
Number of subjects: 86
Study 16721316 — intervention group
Group type: EXPERIMENTAL
Intervention: Long course of family-based therapy (FBT)
Number of subjects: 86
Study 12794603 — intervention group
Group type: EXPERIMENTAL
Intervention: Unidimensional measurement technique
Number of subjects: 86
Study 12794603 — intervention group
Group type: COMPARATOR
Intervention: Bidimensional measurement technique
Number of subjects: 86
Study 11140151 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemoradiation (group 1, n = 9)
Number of subjects: 14
Study 11140151 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemoradiation (group 2, n = 5)
Number of subjects: 14
Study 11140151 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemoradiation (group 1, n = 6)
Number of subjects: 14
Study 11140151 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemoradiation (group 2, n = 4)
Number of subjects: 14
Study 9001838 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg/benazepril 20 mg
Number of subjects: 308
Study 9001838 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine 5 mg
Number of subjects: 308
Study 9001838 — intervention group
Group type: COMPARATOR
Intervention: Benazepril 20 mg
Number of subjects: 308
Study 9001838 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 308
Study 1459173 — intervention group
Group type: EXPERIMENTAL
Intervention: n‐3 polyunsaturated fatty acids (n‐3 PUFA) supplementation (3.6 g, 12 weeks)
Number of subjects: 51
Study 1459173 — intervention group
Group type: COMPARATOR
Intervention: Placebo (six capsules with fat composition as the average Danish diet)
Number of subjects: 51
Study 3881418 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimipramine
Number of subjects: 42
Study 3881418 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 31400177 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative research alongside RCTs focusing on illicit drug use
Number of subjects: 0
Study 31400177 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporal parallel purpose framework
Number of subjects: 0
Study 31400177 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative research
Number of subjects: 0
Study 29718171 — intervention group
Group type: EXPERIMENTAL
Intervention: NHS AKI e-alerts
Number of subjects: 251
Study 29718171 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational outreach programme
Number of subjects: 251
Study 29718171 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined interventions (e-alerts and educational outreach)
Number of subjects: 251
Study 27021751 — intervention group
Group type: EXPERIMENTAL
Intervention: IVR
Number of subjects: 21752
Study 27021751 — intervention group
Group type: EXPERIMENTAL
Intervention: IVR+
Number of subjects: 21752
Study 27021751 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 21752
Study 27021751 — intervention group
Group type: EXPERIMENTAL
Intervention: IVR-based interventions
Number of subjects: 21752
Study 24951468 — intervention group
Group type: EXPERIMENTAL
Intervention: Kids' ITP Tools parent self-report score for recovered patients (n=69)
Number of subjects: 107
Study 24951468 — intervention group
Group type: COMPARATOR
Intervention: Kids' ITP Tools parent self-report score for patients with persistent disease (n=21)
Number of subjects: 107
Study 24951468 — intervention group
Group type: COMPARATOR
Intervention: Health-related quality of life scores between children with mild or moderate bleeding
Number of subjects: 107
Study 24951468 — intervention group
Group type: COMPARATOR
Intervention: Health-related quality of life scores between children who received intravenous immunoglobulin and those who were carefully observed
Number of subjects: 107
Study 22150819 — intervention group
Group type: COMPARATOR
Intervention: No supervision
Number of subjects: 60
Study 22150819 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice weekly supervision
Number of subjects: 60
Study 22150819 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily supervision
Number of subjects: 60
Study 19130298 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitoxantrone plus prednisone (M + P)
Number of subjects: 0
Study 19130298 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel plus estramustine (D + E)
Number of subjects: 0
Study 17268413 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed oil (8 g/day)
Number of subjects: 59
Study 17268413 — intervention group
Group type: COMPARATOR
Intervention: Safflower oil (11 g/day linoleic acid)
Number of subjects: 59
Study 15703464 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel 75 mg + acetylsalicylic acid (ASA) 75 mg daily
Number of subjects: 0
Study 15703464 — intervention group
Group type: COMPARATOR
Intervention: ASA 75 mg/day
Number of subjects: 0
Study 15703464 — intervention group
Group type: COMPARATOR
Intervention: Extended-release dipyridamole 200 mg/low‐dose ASA 25 mg twice daily
Number of subjects: 0
Study 12075263 — intervention group
Group type: EXPERIMENTAL
Intervention: Transmyocardial revascularization (TMR)
Number of subjects: 401
Study 12075263 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous laser revascularization (PTMR)
Number of subjects: 401
Study 12075263 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy (MED(TMR) and MED(PTMR))
Number of subjects: 401
Study 9584297 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper rate programmed to 220-age
Number of subjects: 11
Study 9584297 — intervention group
Group type: COMPARATOR
Intervention: Upper rate programmed to 120 beats/min
Number of subjects: 11
Study 7659199 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane narcotherapy (ISONAR)
Number of subjects: 20
Study 7659199 — intervention group
Group type: COMPARATOR
Intervention: Electroconvulsive treatment (ECT)
Number of subjects: 20
Study 2539838 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (containing EPA and DHA)
Number of subjects: 0
Study 2539838 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (EPA and DHA)
Number of subjects: 0
Study 2539838 — intervention group
Group type: EXPERIMENTAL
Intervention: ALA supplementation
Number of subjects: 0
Study 2539838 — intervention group
Group type: EXPERIMENTAL
Intervention: Preformed EPA
Number of subjects: 0
Study 2539838 — intervention group
Group type: EXPERIMENTAL
Intervention: EPA or DHA supplementation
Number of subjects: 0
Study 2539838 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplements containing DHA
Number of subjects: 0
Study 2539838 — intervention group
Group type: COMPARATOR
Intervention: Control (olive oil)
Number of subjects: 0
Study 2539838 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 18116 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral bucolome (30 mg/kg per day for 5 days)
Number of subjects: 50
Study 18116 — intervention group
Group type: COMPARATOR
Intervention: Control group (no bucolome)
Number of subjects: 50
Study 18116 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral bucolome
Number of subjects: 50
Study 31112406 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 g of milk protein concentrate (MPC80) with 1.5 g of free leucine (15G+LEU)
Number of subjects: 24
Study 31112406 — intervention group
Group type: COMPARATOR
Intervention: 15 g of milk protein concentrate (MPC80) without leucine (15G)
Number of subjects: 24
Study 29300110 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-provided information booklet
Number of subjects: 160
Study 29300110 — intervention group
Group type: COMPARATOR
Intervention: Conventional counselling (control group)
Number of subjects: 160
Study 26012639 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial treatment
Number of subjects: 0
Study 26012639 — intervention group
Group type: COMPARATOR
Intervention: Intravenous tissue-type plasminogen activator alone
Number of subjects: 0
Study 23952326 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin degludec
Number of subjects: 1023
Study 23952326 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 1023
Study 20650976 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention consisting of 12 manual‐based informative sessions on schizophrenia
Number of subjects: 219
Study 20650976 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 219
Study 19377494 — intervention group
Group type: EXPERIMENTAL
Intervention: Left atrial catheter ablation
Number of subjects: 0
Study 19377494 — intervention group
Group type: COMPARATOR
Intervention: Pharmacological therapies
Number of subjects: 0
Study 18007083 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional tidal volume ventilation (10 mL/kg)
Number of subjects: 20
Study 18007083 — intervention group
Group type: COMPARATOR
Intervention: Low tidal volume ventilation (6 mL/kg)
Number of subjects: 20
Study 14670310 — intervention group
Group type: EXPERIMENTAL
Intervention: Adult-type dTpa booster vaccine (Boostrix)
Number of subjects: 0
Study 11922111 — intervention group
Group type: EXPERIMENTAL
Intervention: CAR
Number of subjects: 5
Study 11922111 — intervention group
Group type: EXPERIMENTAL
Intervention: CAF+CAR
Number of subjects: 5
Study 11922111 — intervention group
Group type: COMPARATOR
Intervention: CON
Number of subjects: 5
Study 11922111 — intervention group
Group type: EXPERIMENTAL
Intervention: CAF
Number of subjects: 5
Study 9701196 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese diet (high-starch, low-fat)
Number of subjects: 12
Study 7722345 — intervention group
Group type: EXPERIMENTAL
Intervention: gemfibrozil
Number of subjects: 395
Study 2680678 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled release salbutamol 8 mg twice daily
Number of subjects: 68
Study 2680678 — intervention group
Group type: COMPARATOR
Intervention: Aminophylline 525 or 700 mg twice daily
Number of subjects: 68
Study 577226 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic cranial irradiation (PCI)
Number of subjects: 29
Study 577226 — intervention group
Group type: COMPARATOR
Intervention: Non-prophylactic cranial irradiation (non-PCI)
Number of subjects: 29
Study 31201653 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief cognitive behavioral therapy (bCBT) with physical health module
Number of subjects: 127
Study 31201653 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief cognitive behavioral therapy (bCBT)
Number of subjects: 127
Study 31201653 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care condition
Number of subjects: 127
Study 29393237 — intervention group
Group type: EXPERIMENTAL
Intervention: HFNC
Number of subjects: 272
Study 29393237 — intervention group
Group type: COMPARATOR
Intervention: nCPAP
Number of subjects: 272
Study 26897552 — intervention group
Group type: EXPERIMENTAL
Intervention: Familiar game (Solitaire)
Number of subjects: 30
Study 26897552 — intervention group
Group type: COMPARATOR
Intervention: Novel game (Bubble Xplode)
Number of subjects: 30
Study 26897552 — intervention group
Group type: EXPERIMENTAL
Intervention: Both games (Familiar and Novel)
Number of subjects: 30
Study 25056504 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% human albumin
Number of subjects: 44
Study 25056504 — intervention group
Group type: COMPARATOR
Intervention: 0.9% normal saline
Number of subjects: 44
Study 22468908 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-administered cognitive-behavioral therapy (T-CBT)
Number of subjects: 46
Study 20733446 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily text-message reminders
Number of subjects: 82
Study 20733446 — intervention group
Group type: COMPARATOR
Intervention: Control group (no reminders)
Number of subjects: 82
Study 18026999 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic surgery
Number of subjects: 177
Study 18026999 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 177
Study 18026999 — intervention group
Group type: COMPARATOR
Intervention: Coloanal anastomotic techniques
Number of subjects: 177
Study 18026999 — intervention group
Group type: COMPARATOR
Intervention: Other surgical techniques
Number of subjects: 177
Study 16170973 — intervention group
Group type: EXPERIMENTAL
Intervention: ID/flossette (ID/F)
Number of subjects: 84
Study 16170973 — intervention group
Group type: EXPERIMENTAL
Intervention: ID/pick (ID/P)
Number of subjects: 84
Study 16170973 — intervention group
Group type: COMPARATOR
Intervention: Manual dental floss
Number of subjects: 84
Study 12066206 — intervention group
Group type: EXPERIMENTAL
Intervention: LCAH concomitant with cisplatin
Number of subjects: 81
Study 12066206 — intervention group
Group type: COMPARATOR
Intervention: LCAH alone
Number of subjects: 81
Study 10555659 — intervention group
Group type: EXPERIMENTAL
Intervention: Amantadine
Number of subjects: 17
Study 10555659 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 8867483 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic intervention
Number of subjects: 193
Study 8867483 — intervention group
Group type: COMPARATOR
Intervention: Conventional intervention
Number of subjects: 193
Study 8867483 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Number of subjects: 193
Study 8867483 — intervention group
Group type: COMPARATOR
Intervention: Traditional operative method
Number of subjects: 193
Study 1955620 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with 30% calories from fat, 300 mg cholesterol/day
Number of subjects: 531
Study 1955620 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with 26% calories from fat, 200 mg cholesterol/day
Number of subjects: 531
Study 1955620 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet with 22% calories from fat, 100 mg cholesterol/day
Number of subjects: 531